Comprehensive Fragment Screening of the SARS-CoV-2 Proteome Explores Novel Chemical Space for Drug Development

Detalhes bibliográficos
Autor(a) principal: Autoria Múltipla - ver em notas
Data de Publicação: 2022
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/58051
Resumo: Francisco Gomes Neto - Fundação 0swaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Toxinologia. Rio de Janeiro, RJ, Brasil. Demais Autores: Hannes Berg,[a,b‡] Maria A. Wirtz Martin,[a,b‡] Nadide Altincekic,[a,b‡] Islam Alshamleh,[a,b] Jasleen Kaur Bains,[a,b] Julius Blechar,[a] Betül Ceylan,[a,b] Vanessa de Jesus,[a,b] Karthikeyan Dhamotharan,[b,c] Christin Fuks,[a] Santosh L. Gande,[a,b] Bruno Hargittay,[a,b] Katharina F. Hohmann,[a,b] Marie T. Hutchison,[a,b] Sophie Marianne Korn,[b,c] Robin Krishnathas,[a,b] Felicitas Kutz,[a,b] Verena Linhard,[a,b] Tobias Matzel,[a,b] Nathalie Meiser,[a] Anna Niesteruk,[a,b] Dennis J. Pyper,[a,b] Linda Schulte,[a,b] Sven Trucks,[a] Kamal Azzaoui,[d] Marcel J. J. Blommers,[d] Yojana Gadiya,[e,f] Reagon Karki,[e,f] Andrea Zaliani,[e,f] Philip Gribbon,[e,f] Marcius da Silva Almeida,[g,h] Cristiane Dinis Anobom,[i,j] Anna L. Bula,[k] Matthias Bütikofer,[l] Ícaro Putinhon Caruso,[g,m] Isabella Caterina Felli,[n,o] Andrea T. Da Poian,[g] Gisele Cardoso de Amorim,[g,p] Nikolaos K. Fourkiotis,[q] Angelo Gallo,[q,r] Dhiman Ghosh, i,s] Oksana Gorbatyuk,[t] Bing Hao,[t] Vilius Kurauskas,[u] Lauriane Lecoq,[v] Yunfeng Li,[t] Nathane Cunha Mebus-Antunes,[g] Miguel Mompeán,[w] Thais Cristtina Neves-Martins,[g] Martí Ninot-Pedrosa,[v] Anderson S. Pinheiro,[j] Letizia Pontoriero,[n,o] Yulia Pustovalova,[t] Roland Riek,[l] Angus J. Robertson,[x] Marie Jose Abi Saad,[y] Miguel Á. Treviño,[w] Aikaterini C. Tsika,[q] Fabio C. L. Almeida,[g,i] Ad Bax,[x] Katherine Henzler-Wildman,[u] Jeffrey C. Hoch,[t] Kristaps Jaudzems,[k] Douglas V. Laurents,[w] Julien Orts,[y] Roberta Pierattelli,[n,o] Georgios A. Spyroulias,[q] Elke Duchardt-Ferner,[b,c] Jan Ferner,[a,b] Boris Fürtig,[a,b] Martin Hengesbach,[a] Frank Löhr,[b,c] Nusrat Qureshi,[a,b] Christian Richter,[a,b] Krishna Saxena,[a,b] Andreas Schlundt,[b,c] Sridhar Sreeramulu,[a,b] Anna Wacker,[a,b] Julia E. Weigand,[z] Julia Wirmer-Bartoschek,[a,b] Jens Wöhnert,[b,c] and Harald Schwalbe*[a,b]. Notas- Instituições: [a,b] H. Berg[‡], M. A. Wirtz Martin[‡], N. Altincekic[‡], Dr. I. Alshamleh, J. K. Bains, J. Blechar, B. Ceylan, V. de Jesus, C. Fuks, Dr. S. L. Gande, B. Hargittay, K. F. Hohmann, M. T. Hutchison, R. Krishnathas, F. Kutz, V. Linhard, T. Matzel, N. Meiser, Dr. A. Niesteruk, D. J. Pyper, Dr. L. Schulte, Dr. S. Trucks, Dr. J. Ferner, Dr. B. Fürtig, Dr. M. Hengesbach, Dr. N. Qureshi, Dr. C. Richter, Dr. K. Saxena, Dr. S. Sreeramulu, Dr. A. Wacker, Dr. J. Wirmer-Bartoschek, Dr. Prof. Dr. H. Schwalbe [a] Institute for Organic Chemistry and Chemical Biology, Goethe University Frankfurt, Frankfurt am Main, Germany [b] Center of Biomolecular Magnetic Resonance (BMRZ), Goethe University Frankfurt, Frankfurt am Main, Germany Max-von-LaueStrasse 7+9, 60438 Frankfurt am Main (Germany) E-mail: schwalbe@nmr.uni-frankfurt.de [b,c] K. Dhamotharan, Dr. S. M. Korn, Dr. E. Duchardt-Ferner, Dr. F. Löhr, Dr. A. Schlundt, Prof. Dr. J. Wöhnert [c] Institute for Molecular Biosciences, Goethe University Frankfurt, Frankfurt am Main, Germany Max-von-Laue Strasse 7+9, 60438 Frankfurt am Main (Germany) [d] Dr. K. Azzaoui, Dr. M. J. J. Blommers Saverna Therapeutics, Pumpmattenweg 3, 4105 Biel-Benken, Switzerland [e,f] Y. Gadiya, R. Karki, A. Zaliani, Dr. P. Gribbon [e] Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Screening Port, Schnackenburgallee 114, 22525 Hamburg, Germany [f] Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany [g,h] M. S. Almeida, A. T. Da Poian, N. C. Mebus-Antunes, T. C. Neves-Martins, F. C. L. Almeida [g] Institute of Medical Biochemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil [h] Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany [i,j] C. D Anobom, A. S. Pinheiro [i] National Center of Nuclear Magnetic Resonance (CNRMN), CENABIO, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil [j] Department of Biochemistry, Institute of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil [k] A. L. Bula, K. Jaudzems [k] Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006 Riga, Latvia [l] M. Bütikofer, D. Ghosh, R. Riek [l] ETH, Swiss Federal Institute of Technology, Laboratory of Physical Chemistry, HCI F217, Vladimir-Prelog-Weg 2, 8093 Zürich, Switzerland. [g,m] Í. P. Caruso [m] Multiuser Center for Biomolecular Innovation (CMIB), Department of Physics, São Paulo State University (UNESP), São José do Rio Preto, Brazil [n,o] I. C. Felli, L. Pontoriero, R. Pierattelli [n] Magnetic Resonance Center (CERM), University of Florence, Via Luigi Sacconi 6, Sesto Fiorentino, 50019, Florence, Italy [o] Department of Chemistry "Ugo Schiff", University of Florence, Via della Lastruccia 3-13, Sesto Fiorentino, 50019, Florence, Italy [g,p] G. C. de Amorim [p] Multidisciplinary Center for Research in Biology (NUMPEX), Campus Duque de Caxias Federal University of Rio de Janeiro, Duque de Caxias, Brazil [q] N. K. Fourkiotis, A. C. Tsika, G. A. Spyroulias [q] Department of Pharmacy, University of Patras, Patras, Greece [q,r] A. Gallo, [r] Department of Chemistry, University of Torino IT -10126 Torino. Italy [i,s] F. Gomes-Neto [s] Laboratory of Toxinology, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil [t] O. Gorbatyuk, B. Hao, Y. Li, Y. Pustovalova, J. C. Hoch [t] Department of Molecular Biology and Biophysics UConn Health 263 Farmington Ave., Farmington, CT 06030-3305 USA [u] V. Kurauskas, K. Henzler-Wildman [u] Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706 [v] L. Lecoq, M. Ninot-Pedrosa [v] Molecular Microbiology and Structural Biochemistry, UMR5086 CNRS/Université Lyon 1, 7, passage du Vercors, 69367 Lyon, France.
id CRUZ_3bea04d30387c5a0222197eb85b5c5f6
oai_identifier_str oai:www.arca.fiocruz.br:icict/58051
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Autoria Múltipla - ver em notas2023-04-27T19:39:35Z2023-04-27T19:39:35Z2022BERG, Hannes et al. Comprehensive Fragment Screening of the SARS-CoV-2 Proteome Explores Novel Chemical Space for Drug Development. Angew. Chem. Int. Ed., 2022, e202205858.1521-3773https://www.arca.fiocruz.br/handle/icict/5805110.1002/anie.202205858Francisco Gomes Neto - Fundação 0swaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Toxinologia. Rio de Janeiro, RJ, Brasil. Demais Autores: Hannes Berg,[a,b‡] Maria A. Wirtz Martin,[a,b‡] Nadide Altincekic,[a,b‡] Islam Alshamleh,[a,b] Jasleen Kaur Bains,[a,b] Julius Blechar,[a] Betül Ceylan,[a,b] Vanessa de Jesus,[a,b] Karthikeyan Dhamotharan,[b,c] Christin Fuks,[a] Santosh L. Gande,[a,b] Bruno Hargittay,[a,b] Katharina F. Hohmann,[a,b] Marie T. Hutchison,[a,b] Sophie Marianne Korn,[b,c] Robin Krishnathas,[a,b] Felicitas Kutz,[a,b] Verena Linhard,[a,b] Tobias Matzel,[a,b] Nathalie Meiser,[a] Anna Niesteruk,[a,b] Dennis J. Pyper,[a,b] Linda Schulte,[a,b] Sven Trucks,[a] Kamal Azzaoui,[d] Marcel J. J. Blommers,[d] Yojana Gadiya,[e,f] Reagon Karki,[e,f] Andrea Zaliani,[e,f] Philip Gribbon,[e,f] Marcius da Silva Almeida,[g,h] Cristiane Dinis Anobom,[i,j] Anna L. Bula,[k] Matthias Bütikofer,[l] Ícaro Putinhon Caruso,[g,m] Isabella Caterina Felli,[n,o] Andrea T. Da Poian,[g] Gisele Cardoso de Amorim,[g,p] Nikolaos K. Fourkiotis,[q] Angelo Gallo,[q,r] Dhiman Ghosh, i,s] Oksana Gorbatyuk,[t] Bing Hao,[t] Vilius Kurauskas,[u] Lauriane Lecoq,[v] Yunfeng Li,[t] Nathane Cunha Mebus-Antunes,[g] Miguel Mompeán,[w] Thais Cristtina Neves-Martins,[g] Martí Ninot-Pedrosa,[v] Anderson S. Pinheiro,[j] Letizia Pontoriero,[n,o] Yulia Pustovalova,[t] Roland Riek,[l] Angus J. Robertson,[x] Marie Jose Abi Saad,[y] Miguel Á. Treviño,[w] Aikaterini C. Tsika,[q] Fabio C. L. Almeida,[g,i] Ad Bax,[x] Katherine Henzler-Wildman,[u] Jeffrey C. Hoch,[t] Kristaps Jaudzems,[k] Douglas V. Laurents,[w] Julien Orts,[y] Roberta Pierattelli,[n,o] Georgios A. Spyroulias,[q] Elke Duchardt-Ferner,[b,c] Jan Ferner,[a,b] Boris Fürtig,[a,b] Martin Hengesbach,[a] Frank Löhr,[b,c] Nusrat Qureshi,[a,b] Christian Richter,[a,b] Krishna Saxena,[a,b] Andreas Schlundt,[b,c] Sridhar Sreeramulu,[a,b] Anna Wacker,[a,b] Julia E. Weigand,[z] Julia Wirmer-Bartoschek,[a,b] Jens Wöhnert,[b,c] and Harald Schwalbe*[a,b]. Notas- Instituições: [a,b] H. Berg[‡], M. A. Wirtz Martin[‡], N. Altincekic[‡], Dr. I. Alshamleh, J. K. Bains, J. Blechar, B. Ceylan, V. de Jesus, C. Fuks, Dr. S. L. Gande, B. Hargittay, K. F. Hohmann, M. T. Hutchison, R. Krishnathas, F. Kutz, V. Linhard, T. Matzel, N. Meiser, Dr. A. Niesteruk, D. J. Pyper, Dr. L. Schulte, Dr. S. Trucks, Dr. J. Ferner, Dr. B. Fürtig, Dr. M. Hengesbach, Dr. N. Qureshi, Dr. C. Richter, Dr. K. Saxena, Dr. S. Sreeramulu, Dr. A. Wacker, Dr. J. Wirmer-Bartoschek, Dr. Prof. Dr. H. Schwalbe [a] Institute for Organic Chemistry and Chemical Biology, Goethe University Frankfurt, Frankfurt am Main, Germany [b] Center of Biomolecular Magnetic Resonance (BMRZ), Goethe University Frankfurt, Frankfurt am Main, Germany Max-von-LaueStrasse 7+9, 60438 Frankfurt am Main (Germany) E-mail: schwalbe@nmr.uni-frankfurt.de [b,c] K. Dhamotharan, Dr. S. M. Korn, Dr. E. Duchardt-Ferner, Dr. F. Löhr, Dr. A. Schlundt, Prof. Dr. J. Wöhnert [c] Institute for Molecular Biosciences, Goethe University Frankfurt, Frankfurt am Main, Germany Max-von-Laue Strasse 7+9, 60438 Frankfurt am Main (Germany) [d] Dr. K. Azzaoui, Dr. M. J. J. Blommers Saverna Therapeutics, Pumpmattenweg 3, 4105 Biel-Benken, Switzerland [e,f] Y. Gadiya, R. Karki, A. Zaliani, Dr. P. Gribbon [e] Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Screening Port, Schnackenburgallee 114, 22525 Hamburg, Germany [f] Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany [g,h] M. S. Almeida, A. T. Da Poian, N. C. Mebus-Antunes, T. C. Neves-Martins, F. C. L. Almeida [g] Institute of Medical Biochemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil [h] Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany [i,j] C. D Anobom, A. S. Pinheiro [i] National Center of Nuclear Magnetic Resonance (CNRMN), CENABIO, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil [j] Department of Biochemistry, Institute of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil [k] A. L. Bula, K. Jaudzems [k] Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006 Riga, Latvia [l] M. Bütikofer, D. Ghosh, R. Riek [l] ETH, Swiss Federal Institute of Technology, Laboratory of Physical Chemistry, HCI F217, Vladimir-Prelog-Weg 2, 8093 Zürich, Switzerland. [g,m] Í. P. Caruso [m] Multiuser Center for Biomolecular Innovation (CMIB), Department of Physics, São Paulo State University (UNESP), São José do Rio Preto, Brazil [n,o] I. C. Felli, L. Pontoriero, R. Pierattelli [n] Magnetic Resonance Center (CERM), University of Florence, Via Luigi Sacconi 6, Sesto Fiorentino, 50019, Florence, Italy [o] Department of Chemistry "Ugo Schiff", University of Florence, Via della Lastruccia 3-13, Sesto Fiorentino, 50019, Florence, Italy [g,p] G. C. de Amorim [p] Multidisciplinary Center for Research in Biology (NUMPEX), Campus Duque de Caxias Federal University of Rio de Janeiro, Duque de Caxias, Brazil [q] N. K. Fourkiotis, A. C. Tsika, G. A. Spyroulias [q] Department of Pharmacy, University of Patras, Patras, Greece [q,r] A. Gallo, [r] Department of Chemistry, University of Torino IT -10126 Torino. Italy [i,s] F. Gomes-Neto [s] Laboratory of Toxinology, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil [t] O. Gorbatyuk, B. Hao, Y. Li, Y. Pustovalova, J. C. Hoch [t] Department of Molecular Biology and Biophysics UConn Health 263 Farmington Ave., Farmington, CT 06030-3305 USA [u] V. Kurauskas, K. Henzler-Wildman [u] Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706 [v] L. Lecoq, M. Ninot-Pedrosa [v] Molecular Microbiology and Structural Biochemistry, UMR5086 CNRS/Université Lyon 1, 7, passage du Vercors, 69367 Lyon, France.Autoria Múltipla - ver em notasSARS-CoV-2 (SCoV2) and its variants of concern pose serious challenges to the public health. The variants increased challenges to vaccines, thus necessitating for development of new intervention strategies including anti-virals. Within the international Covid19-NMR consortium, we have identified binders targeting the RNA genome of SCoV2. We established protocols for the production and NMR characterization of more than 80% of all SCoV2 proteins. Here, we performed an NMR screening using a fragment library for binding to 25 SCoV2 proteins and identified hits also against previously unexplored SCoV2 proteins. Computational mapping was used to predict binding sites and identify functional moieties (chemotypes) of the ligands occupying these pockets. Striking consensus was observed between NMR-detected binding sites of the main protease and the computational procedure. Our investigation provides novel structural and chemical space for structure-based drug design against the SCoV2 proteome.engWiley-VCHTriagem abrangente de fragmentos do SARS-CoV-2Proteome - novo espaço químicoDesenvolvimento de medicamentosComprehensive Fragment Screening of the SARS-CoV-2Proteome Explores Novel Chemical SpaceFor Drug DevelopmentComprehensive Fragment Screening of the SARS-CoV-2 Proteome Explores Novel Chemical Space for Drug Developmentinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/58051/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALAngew Chem Int Ed - 2022 - Berg - Comprehensive Fragment Screening of the SARS‐CoV‐2 Proteome Explores Novel Chemical Space.pdfAngew Chem Int Ed - 2022 - Berg - Comprehensive Fragment Screening of the SARS‐CoV‐2 Proteome Explores Novel Chemical Space.pdfapplication/pdf1827070https://www.arca.fiocruz.br/bitstream/icict/58051/3/Angew%20Chem%20Int%20Ed%20-%202022%20-%20Berg%20-%20Comprehensive%20Fragment%20Screening%20of%20the%20SARS%e2%80%90CoV%e2%80%902%20Proteome%20Explores%20Novel%20Chemical%20Space.pdfcf3c65c7fdcdf522fdc67ece0bbea193MD53THUMBNAILAngew Chem Int Ed - 2022 - Berg - Comprehensive Fragment Screening of the SARS‐CoV‐2 Proteome Explores Novel Chemical Space.jpgAngew Chem Int Ed - 2022 - Berg - Comprehensive Fragment Screening of the SARS‐CoV‐2 Proteome Explores Novel Chemical Space.jpgimage/jpeg266106https://www.arca.fiocruz.br/bitstream/icict/58051/4/Angew%20Chem%20Int%20Ed%20-%202022%20-%20Berg%20-%20Comprehensive%20Fragment%20Screening%20of%20the%20SARS%e2%80%90CoV%e2%80%902%20Proteome%20Explores%20Novel%20Chemical%20Space.jpgd15e1750e34b374b94b0b439486aed5cMD54icict/580512023-09-14 15:53:30.344oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-09-14T18:53:30Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.en_US.fl_str_mv Comprehensive Fragment Screening of the SARS-CoV-2 Proteome Explores Novel Chemical Space for Drug Development
title Comprehensive Fragment Screening of the SARS-CoV-2 Proteome Explores Novel Chemical Space for Drug Development
spellingShingle Comprehensive Fragment Screening of the SARS-CoV-2 Proteome Explores Novel Chemical Space for Drug Development
Autoria Múltipla - ver em notas
Triagem abrangente de fragmentos do SARS-CoV-2
Proteome - novo espaço químico
Desenvolvimento de medicamentos
Comprehensive Fragment Screening of the SARS-CoV-2
Proteome Explores Novel Chemical Space
For Drug Development
title_short Comprehensive Fragment Screening of the SARS-CoV-2 Proteome Explores Novel Chemical Space for Drug Development
title_full Comprehensive Fragment Screening of the SARS-CoV-2 Proteome Explores Novel Chemical Space for Drug Development
title_fullStr Comprehensive Fragment Screening of the SARS-CoV-2 Proteome Explores Novel Chemical Space for Drug Development
title_full_unstemmed Comprehensive Fragment Screening of the SARS-CoV-2 Proteome Explores Novel Chemical Space for Drug Development
title_sort Comprehensive Fragment Screening of the SARS-CoV-2 Proteome Explores Novel Chemical Space for Drug Development
author Autoria Múltipla - ver em notas
author_facet Autoria Múltipla - ver em notas
author_role author
dc.contributor.author.fl_str_mv Autoria Múltipla - ver em notas
dc.subject.other.en_US.fl_str_mv Triagem abrangente de fragmentos do SARS-CoV-2
Proteome - novo espaço químico
Desenvolvimento de medicamentos
topic Triagem abrangente de fragmentos do SARS-CoV-2
Proteome - novo espaço químico
Desenvolvimento de medicamentos
Comprehensive Fragment Screening of the SARS-CoV-2
Proteome Explores Novel Chemical Space
For Drug Development
dc.subject.en.en_US.fl_str_mv Comprehensive Fragment Screening of the SARS-CoV-2
Proteome Explores Novel Chemical Space
For Drug Development
description Francisco Gomes Neto - Fundação 0swaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Toxinologia. Rio de Janeiro, RJ, Brasil. Demais Autores: Hannes Berg,[a,b‡] Maria A. Wirtz Martin,[a,b‡] Nadide Altincekic,[a,b‡] Islam Alshamleh,[a,b] Jasleen Kaur Bains,[a,b] Julius Blechar,[a] Betül Ceylan,[a,b] Vanessa de Jesus,[a,b] Karthikeyan Dhamotharan,[b,c] Christin Fuks,[a] Santosh L. Gande,[a,b] Bruno Hargittay,[a,b] Katharina F. Hohmann,[a,b] Marie T. Hutchison,[a,b] Sophie Marianne Korn,[b,c] Robin Krishnathas,[a,b] Felicitas Kutz,[a,b] Verena Linhard,[a,b] Tobias Matzel,[a,b] Nathalie Meiser,[a] Anna Niesteruk,[a,b] Dennis J. Pyper,[a,b] Linda Schulte,[a,b] Sven Trucks,[a] Kamal Azzaoui,[d] Marcel J. J. Blommers,[d] Yojana Gadiya,[e,f] Reagon Karki,[e,f] Andrea Zaliani,[e,f] Philip Gribbon,[e,f] Marcius da Silva Almeida,[g,h] Cristiane Dinis Anobom,[i,j] Anna L. Bula,[k] Matthias Bütikofer,[l] Ícaro Putinhon Caruso,[g,m] Isabella Caterina Felli,[n,o] Andrea T. Da Poian,[g] Gisele Cardoso de Amorim,[g,p] Nikolaos K. Fourkiotis,[q] Angelo Gallo,[q,r] Dhiman Ghosh, i,s] Oksana Gorbatyuk,[t] Bing Hao,[t] Vilius Kurauskas,[u] Lauriane Lecoq,[v] Yunfeng Li,[t] Nathane Cunha Mebus-Antunes,[g] Miguel Mompeán,[w] Thais Cristtina Neves-Martins,[g] Martí Ninot-Pedrosa,[v] Anderson S. Pinheiro,[j] Letizia Pontoriero,[n,o] Yulia Pustovalova,[t] Roland Riek,[l] Angus J. Robertson,[x] Marie Jose Abi Saad,[y] Miguel Á. Treviño,[w] Aikaterini C. Tsika,[q] Fabio C. L. Almeida,[g,i] Ad Bax,[x] Katherine Henzler-Wildman,[u] Jeffrey C. Hoch,[t] Kristaps Jaudzems,[k] Douglas V. Laurents,[w] Julien Orts,[y] Roberta Pierattelli,[n,o] Georgios A. Spyroulias,[q] Elke Duchardt-Ferner,[b,c] Jan Ferner,[a,b] Boris Fürtig,[a,b] Martin Hengesbach,[a] Frank Löhr,[b,c] Nusrat Qureshi,[a,b] Christian Richter,[a,b] Krishna Saxena,[a,b] Andreas Schlundt,[b,c] Sridhar Sreeramulu,[a,b] Anna Wacker,[a,b] Julia E. Weigand,[z] Julia Wirmer-Bartoschek,[a,b] Jens Wöhnert,[b,c] and Harald Schwalbe*[a,b]. Notas- Instituições: [a,b] H. Berg[‡], M. A. Wirtz Martin[‡], N. Altincekic[‡], Dr. I. Alshamleh, J. K. Bains, J. Blechar, B. Ceylan, V. de Jesus, C. Fuks, Dr. S. L. Gande, B. Hargittay, K. F. Hohmann, M. T. Hutchison, R. Krishnathas, F. Kutz, V. Linhard, T. Matzel, N. Meiser, Dr. A. Niesteruk, D. J. Pyper, Dr. L. Schulte, Dr. S. Trucks, Dr. J. Ferner, Dr. B. Fürtig, Dr. M. Hengesbach, Dr. N. Qureshi, Dr. C. Richter, Dr. K. Saxena, Dr. S. Sreeramulu, Dr. A. Wacker, Dr. J. Wirmer-Bartoschek, Dr. Prof. Dr. H. Schwalbe [a] Institute for Organic Chemistry and Chemical Biology, Goethe University Frankfurt, Frankfurt am Main, Germany [b] Center of Biomolecular Magnetic Resonance (BMRZ), Goethe University Frankfurt, Frankfurt am Main, Germany Max-von-LaueStrasse 7+9, 60438 Frankfurt am Main (Germany) E-mail: schwalbe@nmr.uni-frankfurt.de [b,c] K. Dhamotharan, Dr. S. M. Korn, Dr. E. Duchardt-Ferner, Dr. F. Löhr, Dr. A. Schlundt, Prof. Dr. J. Wöhnert [c] Institute for Molecular Biosciences, Goethe University Frankfurt, Frankfurt am Main, Germany Max-von-Laue Strasse 7+9, 60438 Frankfurt am Main (Germany) [d] Dr. K. Azzaoui, Dr. M. J. J. Blommers Saverna Therapeutics, Pumpmattenweg 3, 4105 Biel-Benken, Switzerland [e,f] Y. Gadiya, R. Karki, A. Zaliani, Dr. P. Gribbon [e] Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Screening Port, Schnackenburgallee 114, 22525 Hamburg, Germany [f] Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany [g,h] M. S. Almeida, A. T. Da Poian, N. C. Mebus-Antunes, T. C. Neves-Martins, F. C. L. Almeida [g] Institute of Medical Biochemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil [h] Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany [i,j] C. D Anobom, A. S. Pinheiro [i] National Center of Nuclear Magnetic Resonance (CNRMN), CENABIO, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil [j] Department of Biochemistry, Institute of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil [k] A. L. Bula, K. Jaudzems [k] Latvian Institute of Organic Synthesis, Aizkraukles 21, LV-1006 Riga, Latvia [l] M. Bütikofer, D. Ghosh, R. Riek [l] ETH, Swiss Federal Institute of Technology, Laboratory of Physical Chemistry, HCI F217, Vladimir-Prelog-Weg 2, 8093 Zürich, Switzerland. [g,m] Í. P. Caruso [m] Multiuser Center for Biomolecular Innovation (CMIB), Department of Physics, São Paulo State University (UNESP), São José do Rio Preto, Brazil [n,o] I. C. Felli, L. Pontoriero, R. Pierattelli [n] Magnetic Resonance Center (CERM), University of Florence, Via Luigi Sacconi 6, Sesto Fiorentino, 50019, Florence, Italy [o] Department of Chemistry "Ugo Schiff", University of Florence, Via della Lastruccia 3-13, Sesto Fiorentino, 50019, Florence, Italy [g,p] G. C. de Amorim [p] Multidisciplinary Center for Research in Biology (NUMPEX), Campus Duque de Caxias Federal University of Rio de Janeiro, Duque de Caxias, Brazil [q] N. K. Fourkiotis, A. C. Tsika, G. A. Spyroulias [q] Department of Pharmacy, University of Patras, Patras, Greece [q,r] A. Gallo, [r] Department of Chemistry, University of Torino IT -10126 Torino. Italy [i,s] F. Gomes-Neto [s] Laboratory of Toxinology, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil [t] O. Gorbatyuk, B. Hao, Y. Li, Y. Pustovalova, J. C. Hoch [t] Department of Molecular Biology and Biophysics UConn Health 263 Farmington Ave., Farmington, CT 06030-3305 USA [u] V. Kurauskas, K. Henzler-Wildman [u] Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706 [v] L. Lecoq, M. Ninot-Pedrosa [v] Molecular Microbiology and Structural Biochemistry, UMR5086 CNRS/Université Lyon 1, 7, passage du Vercors, 69367 Lyon, France.
publishDate 2022
dc.date.issued.fl_str_mv 2022
dc.date.accessioned.fl_str_mv 2023-04-27T19:39:35Z
dc.date.available.fl_str_mv 2023-04-27T19:39:35Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv BERG, Hannes et al. Comprehensive Fragment Screening of the SARS-CoV-2 Proteome Explores Novel Chemical Space for Drug Development. Angew. Chem. Int. Ed., 2022, e202205858.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/58051
dc.identifier.issn.en_US.fl_str_mv 1521-3773
dc.identifier.doi.none.fl_str_mv 10.1002/anie.202205858
identifier_str_mv BERG, Hannes et al. Comprehensive Fragment Screening of the SARS-CoV-2 Proteome Explores Novel Chemical Space for Drug Development. Angew. Chem. Int. Ed., 2022, e202205858.
1521-3773
10.1002/anie.202205858
url https://www.arca.fiocruz.br/handle/icict/58051
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Wiley-VCH
publisher.none.fl_str_mv Wiley-VCH
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/58051/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/58051/3/Angew%20Chem%20Int%20Ed%20-%202022%20-%20Berg%20-%20Comprehensive%20Fragment%20Screening%20of%20the%20SARS%e2%80%90CoV%e2%80%902%20Proteome%20Explores%20Novel%20Chemical%20Space.pdf
https://www.arca.fiocruz.br/bitstream/icict/58051/4/Angew%20Chem%20Int%20Ed%20-%202022%20-%20Berg%20-%20Comprehensive%20Fragment%20Screening%20of%20the%20SARS%e2%80%90CoV%e2%80%902%20Proteome%20Explores%20Novel%20Chemical%20Space.jpg
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
cf3c65c7fdcdf522fdc67ece0bbea193
d15e1750e34b374b94b0b439486aed5c
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798324661585444864